IQVIA Holdings, Inc. (IQV) News
Filter IQV News Items
IQV News Results
|Loading, please wait...|
IQV News Highlights
- For IQV, its 30 day story count is now at 22.
- Over the past 16 days, the trend for IQV's stories per day has been choppy and unclear. It has oscillated between 1 and 11.
- NRXP and MA are the most mentioned tickers in articles about IQV.
Latest IQV News From Around the Web
Below are the latest news stories about Iqvia Holdings Inc that investors may wish to consider to help them evaluate IQV as an investment opportunity.
Encouraging yearly guidance and consecutive better-than-expected top- and bottom-line performances have been aiding IQVIA Holdings' (IQV) stock.
IQVIA Holdings found using ticker (IQV) have now 19 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 300 and 235 calculating the average target price we see 278.16. Given that the stocks previous close was at 257.55 this would indicate that there is a potential upside of 8.0%. The 50 day MA is 254.71 and the 200 day moving average is 232.03. The market capitalisation for the company is $49,604m. Find out more information at: /> [stock_market_widget type="chart" symbol="IQV" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Amer...
Iqvia Holdings Inc (NYSE: IQV ) has collaborated with NRx Pharmaceuticals Inc (NASDAQ: NRXP ) to provide pharmacovigilance services and medical information in preparation for potential Full story available on Benzinga.com
IQVIA (IQV) and NRx are set to work closely to support activities essential for emergency use authorization of ZYESAMI.
RESEARCH TRIANGLE PARK, N.C., September 13, 2021--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a transformative collaboration with NRx Pharmaceuticals (NRx) (Nasdaq: NRXP). NRx is a company dedicated to creating innovative, life-saving treatments and bringing hope to those facing life-altering conditions with no approved disease-modifying therapies or cures. IQVIA is excited
RESEARCH TRIANGLE PARK, N.C., September 08, 2021--IQVIA™ (NYSE: IQV) announces its strategic collaboration with HealthCore, Inc., a leading real world research organization in the United States, to advance real world evidence (RWE) studies with increased quality and efficiency. RWE studies incorporate innovative scientific methods with dynamic data from sources such as electronic medical records, pharmacy and medical claims, laboratory and genomics records, and patient-reported outcomes.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Regulatory Reporting and Compliance Market 2021 Analysis, Reviews and Precise Outlook | Genpact Ltd., IQVIA Holdings Inc, Certara, L.P., Pharmaceutical Product Development, LLC (PPD), and Charles River Laboratories International, Inc.
The Regulatory Reporting and Compliance market studied is expected to grow with a CAGR of +9 % over the forecast period. The regulatory bodies remain strict and stick to their regulatory process but with the outbreak of the COVID-19 pandemic, they
IQVIA CFO, Ron Bruehlman, to Speak at the Baird 2021 Global Healthcare Conference on September 14, 2021
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the Baird 2021 Global Healthcare Conference on Tuesday, September 14, 2021 at 12:15 p.m. EDT. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day
RESEARCH TRIANGLE PARK, N.C., September 01, 2021--IQVIA™ (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced it has added new AI-powered technologies to enhance its existing Medical Information (MI) Contact Center services.